Dr. Reddy's Laboratories
DRREDDY · Pharma > Pharmaceuticals & Drugs · Chairman: K Satish Reddy · MD: GV Prasad · Listing date: Oct. 24, 1994 · Employees: 22739 · Hyderabad · http://www.drreddys.com

Stock Price vs Company Growth
1d
1.1%
1w
2.2%
1m
7.3%
3m
12.9%
6m
10.2%
1y
7.3%
5y
5.3%
10y
7.5%
all
12.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,369 1.1%
1,196
1,414
Company Overview

Sales
33,700 Cr
Growth: 9.4%
Profit after Tax
4,196 Cr
Growth: -24.6%
Large Cap
1,14,275 Cr
P/E: 27.2x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 33,700
Growth 9.4%
EBITDA 19.1%
P/S 3.4x
Dividend 0.6%
P/E 27.2x
Book Value ₹ 454
PEG Ratio 2.9x
ROE 11.4%
P/B 3.0x
Shareholding Pattern

Institutions
First Senter Investors Icvc- Stewart Investors Asia Pacific Leaders Sustainability Fund
3.37 %
Life Insurance Corporation Of India P & Gs Fund
2.34 %
Sbi Mutual Fund
2.11 %
Aditya Birla Mutual Fund
1.96 %
Government Of Singapore - E
1.77 %
Promoters
Dr. Reddy'S Holdings Limited
24.84 %
Gunupati Venkateswara Prasad (Huf)
0.67 %
Samrajyam Reddy Kallam
0.67 %
Satish Reddy Kallam
0.54 %
Others
Jp Morgan Chase Bank, Na
12.09 %
Icici Prudential Life Insurance Company Limited
1.38 %
Nps Trust - A/C
1.27 %
Iepf
0.14 %
Increase    Decrease    No change
Company Profile Detailed

The company is a multinational pharmaceutical company that manufactures and markets a wide range of pharmaceutical products and services. Through its businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.
Investors (388)
Followers (34)